Tag: Patents
Stem Cell Patent Survives Challenge Over Prior Art and Claim Construction
March 4, 2025
Restem, LLC v. Jadi Cell, LLC Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the validity of Jadi Cell, LLC’s U.S. Patent No. 9,803,176, which covers a method for obtaining stem cells from the subepithelial…
Read MorePatent Board Affirms Rejection of DeepMind’s Machine Learning Patent Application, Citing Obviousness and Lack of Patent-Eligible Subject Matter
March 4, 2025
USPTO Authored by: Jeremy J. Gustrowsky A recent decision from the Patent Trial and Appeal Board (PTAB) highlights the challenges of patenting advances in artificial intelligence and machine learning. In the appeal concerning U.S. Patent Application No. 16/319,040, filed by…
Read MoreUnderstanding Patents: What Every Inventor Should Know
February 12, 2025
When it comes to patents, understanding what they protect is key for inventors and creators alike. The most common type, the utility patent, safeguards useful inventions. This could encompass a wide range of innovations, such as processes, machines, chemical compounds,…
Read MoreIPR Decisions Don’t Always Block Patent Claims in Court, Says Federal Circuit
February 10, 2025
Kroy IP Holdings, LLC v. Groupon, Inc Authored by: Jeremy J. Gustrowsky In the recent case of Kroy IP Holdings, LLC v. Groupon, Inc., the Federal Circuit addressed a key question in patent law: Does a decision by the Patent…
Read MorePatent Owners Get a Win: Federal Circuit Limits Collateral Estoppel from PTAB Decisions
February 10, 2025
Kroy IP Holdings, LLC v. Groupon, Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent owners, the Federal Circuit recently clarified when a prior Patent Trial and Appeal Board (PTAB) decision can prevent a patentee from asserting…
Read MorePlant-Based Albumin Patent Survives Import Challenge at the ITC
February 7, 2025
Wuhan Healthgen Biotechnology Corp. v. Int’l Trade Comm’n Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed the International Trade Commission’s (ITC) finding that Wuhan Healthgen Biotechnology Corp. infringed Ventria Bioscience Inc.’s U.S. Patent No. 10,618,951,…
Read MoreFederal Circuit Clarifies “Comprising Tungsten” Means Elemental Tungsten—But Patent Still Obvious
February 6, 2025
HD Silicon Sols. LLC v. Microchip Tech. Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit addressed a key issue in the patent dispute between HD Silicon Solutions LLC and Microchip Technology Inc. over U.S. Patent…
Read MorePatent Office Can Continue Reexams Even After IPRs and Patent Expiration, Court Says
January 27, 2025
In re Gesture Tech. Partners, LLC Authored by: Jeremy J. Gustrowsky A recent decision has clarified how patent challenges can proceed even after multiple rounds of review and the expiration of the patent itself. Gesture Technology Partners, LLC found itself…
Read MoreNavigating Patent Myths: Unlocking Your Business Potential
January 15, 2025
Common misconceptions about the patent system can really hold businesses back from seizing growth opportunities and securing their place in the market, especially when there’s fierce competition out there. One of the biggest myths? “If I patent it, I can…
Read MorePublished Patent Applications Can Be Used as Prior Art in IPRs—Even Before They’re Public
January 14, 2025
Lynk Labs, Inc. v. Samsung Elecs. Co Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified a key question for patent law: Can a published patent application be used as prior art in an inter partes…
Read MoreFederal Circuit Clarifies Written Description for Drug Combination Patents
January 10, 2025
Novartis Pharms. Corp. v. Torrent Pharma Inc. (In re Entresto (Sacubitril_Valsartan)) Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision has important implications for pharmaceutical patents covering drug combinations, especially when new forms of those combinations are discovered after…
Read MorePatent Board Reversed: Motivation for Obviousness Doesn’t Have to Match Inventor’s Reason
January 2, 2025
Honeywell Int’l Inc. v. 3G Licensing, S.A. Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit reversed the Patent Trial and Appeal Board’s (PTAB) finding that claims of U.S. Patent No. 7,319,718 were not obvious. The patent,…
Read More